Obata F - Search Results

1

An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family.

Funayama M, Hasegawa K, Ohta E, Kawashima N, Komiyama M, Kowa H, Tsuji S, Obata F. Funayama M, et al. Among authors: obata f. Ann Neurol. 2005 Jun;57(6):918-21. doi: 10.1002/ana.20484. Ann Neurol. 2005. PMID: 15880653

2

A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1.

Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata F. Funayama M, et al. Among authors: obata f. Ann Neurol. 2002 Mar;51(3):296-301. doi: 10.1002/ana.10113. Ann Neurol. 2002. PMID: 11891824

3

Independent occurrence of I2020T mutation in the kinase domain of the leucine rich repeat kinase 2 gene in Japanese and German Parkinson's disease families.

Ohta E, Hasegawa K, Gasser T, Obata F. Ohta E, et al. Among authors: obata f. Neurosci Lett. 2007 Apr 24;417(1):21-3. doi: 10.1016/j.neulet.2007.02.086. Epub 2007 Mar 16. Neurosci Lett. 2007. PMID: 17395370

4

Prevention of intracellular degradation of I2020T mutant LRRK2 restores its protectivity against apoptosis.

Ohta E, Kubo M, Obata F. Ohta E, et al. Among authors: obata f. Biochem Biophys Res Commun. 2010 Jan 1;391(1):242-7. doi: 10.1016/j.bbrc.2009.11.043. Epub 2009 Nov 11. Biochem Biophys Res Commun. 2010. PMID: 19912990

5

Dominant-negative effects of LRRK2 heterodimers: a possible mechanism of neurodegeneration in Parkinson's disease caused by LRRK2 I2020T mutation.

Ohta E, Kawakami F, Kubo M, Obata F. Ohta E, et al. Among authors: obata f. Biochem Biophys Res Commun. 2013 Jan 11;430(2):560-6. doi: 10.1016/j.bbrc.2012.11.113. Epub 2012 Dec 7. Biochem Biophys Res Commun. 2013. PMID: 23220480

6

Generation of gene-corrected iPSCs line (KEIUi001-A) from a PARK8 patient iPSCs with familial Parkinson's disease carrying the I2020T mutation in LRRK2.

Ohta E, Sone T, Ukai H, Hisamatsu T, Kitagawa T, Ishikawa M, Nagai M, Ueda HR, Obata F, Okano H. Ohta E, et al. Among authors: obata f. Stem Cell Res. 2020 Dec;49:102073. doi: 10.1016/j.scr.2020.102073. Epub 2020 Nov 3. Stem Cell Res. 2020. PMID: 33181472 Free article.

7

Analysis of alpha-synuclein, parkin, tau, and UCH-L1 in a Japanese family with autosomal dominant parkinsonism.

Hasegawa K, Funayama M, Matsuura N, Furusawa H, Sakai F, Kowa H, Obata F. Hasegawa K, et al. Among authors: obata f. Eur Neurol. 2001;46(1):20-4. doi: 10.1159/000050751. Eur Neurol. 2001. PMID: 11455179

8

LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: impairment of the kinase activity by Parkinson's disease-associated mutations.

Ohta E, Kawakami F, Kubo M, Obata F. Ohta E, et al. Among authors: obata f. FEBS Lett. 2011 Jul 21;585(14):2165-70. doi: 10.1016/j.febslet.2011.05.044. Epub 2011 Jun 2. FEBS Lett. 2011. PMID: 21658387 Free article.

9

The mouse/human cross-species heterodimer of leucine-rich repeat kinase 2: possible significance in the transgenic model mouse of Parkinson's disease.

Miyajima T, Ohta E, Kawada H, Maekawa T, Obata F. Miyajima T, et al. Among authors: obata f. Neurosci Lett. 2015 Feb 19;588:142-6. doi: 10.1016/j.neulet.2015.01.003. Epub 2015 Jan 3. Neurosci Lett. 2015. PMID: 25562633

10

Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries.

Tomiyama H, Li Y, Funayama M, Hasegawa K, Yoshino H, Kubo S, Sato K, Hattori T, Lu CS, Inzelberg R, Djaldetti R, Melamed E, Amouri R, Gouider-Khouja N, Hentati F, Hatano Y, Wang M, Imamichi Y, Mizoguchi K, Miyajima H, Obata F, Toda T, Farrer MJ, Mizuno Y, Hattori N. Tomiyama H, et al. Among authors: obata f. Mov Disord. 2006 Aug;21(8):1102-8. doi: 10.1002/mds.20886. Mov Disord. 2006. PMID: 16622854

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters